Lotus Pharmaceuticals Stock Annual Yield
| LTUS Stock | USD 0.0008 0 75.76% |
Lotus Pharmaceuticals fundamentals help investors to digest information that contributes to Lotus Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Lotus Pink Sheet. The fundamental analysis module provides a way to measure Lotus Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lotus Pharmaceuticals pink sheet.
Lotus |
Lotus Pharmaceuticals Company Annual Yield Analysis
Lotus Pharmaceuticals' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Lotus Pharmaceuticals has an Annual Yield of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Lotus Fundamentals
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0456 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 762.17 K | |||
| Shares Outstanding | 27.82 M | |||
| Price To Earning | 0.18 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 72.7 M | |||
| Gross Profit | 39.78 M | |||
| EBITDA | 10.31 M | |||
| Net Income | 14.42 M | |||
| Cash And Equivalents | 158.91 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5.24 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | 3.58 X | |||
| Cash Flow From Operations | 26.78 M | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 233 | |||
| Beta | 0.51 | |||
| Market Capitalization | 834.49 K | |||
| Total Asset | 103.18 M | |||
| Retained Earnings | 65 M | |||
| Working Capital | (6 M) | |||
| Current Asset | 8 M | |||
| Current Liabilities | 14 M | |||
| Net Asset | 103.18 M |
About Lotus Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lotus Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lotus Pink Sheet Analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.